Oruka Therapeutics, Inc. ORKA Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s short- and long-term operating lease liabilities?
- Oruka Therapeutics, Inc. (ORKA) reported short- and long-term operating lease liabilities of -$125K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- Oruka Therapeutics, Inc.'s short- and long-term operating lease liabilities decreased by 495.2% year-over-year, from -$21K to -$125K.
- What does short- and long-term operating lease liabilities mean?
- Measures the net change in the present value of future lease payments for operating assets. This metric is essential for understanding the company's long-term fixed commitments and the impact of lease accounting standards on the balance sheet.